Professor Gareth Morgan, PhD, FRCP, FRCPath

Prof Morgan joined the Board of Myeloma UK in 2001. He became Chairman in 2003 and then President in 2006.
He is Prof of Haematology at the Institute of Cancer Research and Head of the Haemato-Oncology Clinical Unit at the Royal Marsden NHS Foundation.

Prof Morgan is an internationally respected clinician and researcher who has published extensively on the genetics and treatment of blood cancers. His research has focussed on the translation of information derived from the molecular analysis of the pathogenesis of leukaemic cells into the clinic using novel targeted treatment strategies.

In particular, he has developed strategies for the use of new drugs in the context of standard treatment approaches. He is currently Principal Investigator or a number of Phase I, II and III studies as well as serving on independent data monitoring committees.
He reviews for many journals and sits on a number of grant governing bodies both in the UK and internationally. Prof Morgan lives in Wimbledon, is married and has two daughters.

 

 

While the advice and information on this website are believed to be true and accurate at the time of publication, neither the authors, nor the UKMF accept any legal responsibility for their content.